Literature DB >> 18431327

[Polimorphonuclear leukocytes and diabetes mellitus].

E Hopps1, A Camera, G Caimi.   

Abstract

Diabetic subjects have a higher infective risk than healthy people, with more frequent and severe infections. This predisposition to infections is determined by hyperglycemia, microangiopathy and altered immune system. In particular, there is a polymorphonuclear leukocytes disfunction including chemotaxis, phagocytosis, bacterial killing and cellular activation by infective stimulus. These alterations are due to abnormal properties of polymorphonuclear leukocytes (PMN) in diabetic patients. Several parameters like phagocytosis of bacterial cells, chemiluminescence during oxidative burst and cell membrane deformability are related to glycaemia and glycated hemoglobin. Recent acquisitions show an altered integrin pattern on diabetics PMN, at baseline and after in vitro stimulation with soluble stimulus like fMLP or PMA. This could influence the interactions between PMN and endothelial cells and the diapedesis. Receptorial alterations on PMN surface may be ascribed to the abnormalities of the cytoscheleton, of the endocytosis and of the transduction mechanism, due to hyperglycemia.

Entities:  

Mesh:

Year:  2008        PMID: 18431327

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  3 in total

1.  Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Factors of Community- and Hospital-Acquired Urinary Tract Infection at Dessie Referral Hospital, Dessie, Northeast Ethiopia.

Authors:  Berhanu Adugna; Bekele Sharew; Mohabaw Jemal
Journal:  Int J Microbiol       Date:  2021-09-18

2.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

Review 3.  Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation.

Authors:  Ana L Guadarrama-López; Roxana Valdés-Ramos; Beatríz E Martínez-Carrillo
Journal:  J Immunol Res       Date:  2014-02-24       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.